BRAWNPHARMACEUTICALSLTD logo

Brawn Biotech Ltd

BRAWNPHARMACEUTICALSLTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap6.55 Cr
PE Ratio8.00
Volume
Day High - Low
52W High-Low24.37 - 17.71
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
24.40%
Strong
P/E
8.00x
Cheap
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W17.71
24.37
DocStoX take

Supported by valuation (9.0), but held back by growth (1.5). Valuation looks strong at 9.0, but that is offset by growth at 1.5 and quality at 2.1. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Medium confidence
4.0
/10
Weak
Quality
Weak
ROE 24.4%
Valuation
Cheap
P/E 8.0×
Growth
Flat
Revenue -13.5% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹7 Cr
52W High / Low
₹24 / ₹18
Dividend Yield
0.00%
Promoter Holding
52.94%
EPS (TTM)
₹-5.80
Book Value
₹14.47

Key highlights

  • Low leverage — D/E 0.00
  • Undemanding at 8× earnings
  • Strong returns on equity (24%)
  • Profit shrinking 0% a year
  • Revenue shrinking 13% a year
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Brawn Biotech Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.